Keymed Biosciences Co.ltd

This study tested a new medicine called CM310 in 180 teenagers with moderate-to-severe eczema (atopic dermatitis). The goal was to see if it could clear skin and reduce itching better than a placebo. Results showed that more teens using CM310 had significant skin improvement by w…

This early-stage study tested a new medicine called CM512 in 110 healthy volunteers and people with moderate to severe atopic dermatitis (eczema). The main goal was to check safety and how the body processes the drug. Researchers gave either a single or multiple doses and compare…